ANTI-SARS-COV-2 ANTIBODIES

Japanese Patent JP2022130332

A

To provide antibodies that bind to N-protein of SARS-CoV-2 and use methods thereof.SOLUTION: Disclosed is a SARS-CoV-2-binding antibody that comprises one or more structural domains comprising CDRs shown in the following (a) or (b); (a) CDR1 comprising an amino acid sequence of SEQ ID NO:1 or an amino acid sequence where one amino acid substituted by another amino acid in the amino acid sequence of SEQ ID NO:1; CDR2 comprising an amino acid sequence of SEQ ID NO:2 or an amino acid sequence where one amino acid substituted by another amino acid in the amino acid sequence of SEQ ID NO:2; CDR3 comprising an amino acid sequence of SEQ ID NO:3 or an amino acid sequence where one amino acid substituted by another amino acid in the amino acid sequence of SEQ ID NO:3, or (b) CDR1 comprising an amino acid sequence of SEQ ID NO:4 or an amino acid sequence where one amino acid substituted by another amino acid in the amino acid sequence of SEQ ID NO:4; CDR2 comprising an amino acid sequence of SEQ ID NO:5 or an amino acid sequence where one amino acid substituted by another amino acid in the amino acid sequence of SEQ ID NO:5; CDR3 comprising an amino acid sequence of SEQ ID NO:6 or an amino acid sequence where one amino acid substituted by another amino acid in the amino acid sequence of SEQ ID NO:6.SELECTED DRAWING: None

INAURA SHUNSUKE
MATSUMURA YUTA
TOJO TAKAHITO
NAGAMI ATSUSHI

JP2022024995A

September 06, 2022

February 21, 2022

Click for automatic bibliography generation  

KAO CORP
EPSILON MOLECULAR ENG INC

C12N15/13; A61K39/395; A61P31/14; A61P43/00; C07K16/10; G01N33/569

Alga Patent Office, a patent business corporation

Previous Patent: Dental pretreatment material

Next Patent: Redundant power bridge battery architecture